Posted in | News | Energy Sensor

Dynasil Subsidiary Awarded $2.1 Million to Develop Illicit Nuclear Material Identification Equipment

Dynasil Corporation of America today announced that its RMD Research subsidiary has been awarded contracts totaling $2.1 million from the Department of Homeland Security's Domestic Nuclear Detection Office (DNDO). These contracts will advance the government's research and development initiatives focused on the identification of illicit nuclear materials.

"The DNDO continues to tap our highly specialized materials research expertise to develop technology for critical homeland security applications," said Peter Sulick, Dynasil's Chairman of the Board, Interim Chief Executive Officer and President. "These awards focus on the development of next generation materials to combat nuclear smuggling by improving detection of illicit materials at ports, airports, railways and border crossings.

"We believe that our research provides integrated solutions to identify neutron and gamma rays, which are signatures of highly enriched uranium and weapons-grade plutonium," Sulick said. "The threat of terrorists smuggling nuclear materials into the country to create weapons of mass destruction is one of the most serious threats faced by the United States. To prevent this from occurring requires equipping border crossings and shipping ports in the United States and abroad with advanced systems to detect the telltale signature of nuclear materials. RMD's objective is to assist the DNDO in its mission to enhance the nation's nuclear and radiological materials detection capabilities. At the same time, research awards like these help drive Dynasil's commercialization efforts and advance our goal of developing proprietary technology that addresses significant market opportunities."

About Dynasil
Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures detection and analysis technology, precision instruments and optical components for the homeland security, medical and industrial markets including medical imaging and sensors for non-destructive testing. Dynasil has an impressive and growing portfolio of issued and pending U.S. patents. The Company is based in Watertown, Massachusetts, with additional operations in MA, MN, NY, NJ and the United Kingdom. More information about the Company is available at www.dynasil.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dynasil Corporation. (2019, February 24). Dynasil Subsidiary Awarded $2.1 Million to Develop Illicit Nuclear Material Identification Equipment. AZoSensors. Retrieved on November 21, 2024 from https://www.azosensors.com/news.aspx?newsID=7286.

  • MLA

    Dynasil Corporation. "Dynasil Subsidiary Awarded $2.1 Million to Develop Illicit Nuclear Material Identification Equipment". AZoSensors. 21 November 2024. <https://www.azosensors.com/news.aspx?newsID=7286>.

  • Chicago

    Dynasil Corporation. "Dynasil Subsidiary Awarded $2.1 Million to Develop Illicit Nuclear Material Identification Equipment". AZoSensors. https://www.azosensors.com/news.aspx?newsID=7286. (accessed November 21, 2024).

  • Harvard

    Dynasil Corporation. 2019. Dynasil Subsidiary Awarded $2.1 Million to Develop Illicit Nuclear Material Identification Equipment. AZoSensors, viewed 21 November 2024, https://www.azosensors.com/news.aspx?newsID=7286.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.